Guidance: What The Patient Prefers, And How To Make It Part Of Your FDA Submission
This article was originally published in The Gray Sheet
FDA draft guidance lays out how to collect patient preference data and how to present the preferences on device labels. The guidance supports a growing emphasis by FDA to formally incorporate patient input into regulatory decision-making.
Register for our free email digests: